What is the role of an independent data-monitoring committee (IDMC) in a clinical trial?

• A. To manage the trial finances.
• B. To assess the progress of the trial, including safety data and key efficacy endpoints, and to recommend whether to continue, modify, or stop the trial.
• C. To write the final study report.
• D. To recruit participants.

Answer: (B)

The key idea is that an independent data-monitoring committee provides unbiased, ongoing oversight of safety and important efficacy data in a trial, and it has the authority to recommend whether the study should continue, be modified, or be stopped early. This committee reviews interim data at prespecified times, focusing on participant safety, adverse events, and whether the treatment is showing a favorable risk-benefit balance or already meeting stopping criteria for efficacy or futility. By being independent from trial conduct, they help protect volunteers and reduce bias in the decision to continue or stop the study. This role is distinct from other functions: finances are handled by sponsors or trial management, final study reports are written by investigators and statisticians, and participant recruitment is carried out by site staff. The IDMC’s recommendations guide major trial decisions, but the formal action often involves sponsors and regulators, once the panel has weighed the data.